Orthopedic Volume Trends Remained Strong in Fourth Quarter
Stay up to date on the orthopedic market's 4Q performance in 2023 as we update this post with company sales data and industry developments. Mar 18, 2024
Anika Therapeutics to Refocus After Strategic Review
The company grew in the low double-digits in 2023 but a strategic review revealed Anika's need to focus on the greatest growth opportunities. Mar 15, 2024
Medartis’ Focus on Lower Extremities Drives Share Gains
The company grew in the mid-teens in 2023 with significant growth across product segments and most regions. Mar 14, 2024
Bioventus Aligns Priorities Under New Leadership
The company turned in a strong fourth quarter to push 2023 orthopedic sales growth into the low-single-digits. Mar 14, 2024
Medacta Drives Robust Growth Across Segments and Regions
The company grew in the high teens for 2023, driven by its personalized solutions and strength across geographic regions. Mar 13, 2024
OrthoPediatrics Aims for 50% Trauma and Deformity Share
The company grew more than 20% in 2023 as it consistently wins share in its Trauma and Deformity business. Mar 11, 2024
BONESUPPORT Doubled Its North American Sales in 2023
The company grew nearly 80% in 2023, with 104% growth in North America on the strength of CERAMENT G sales in the U.S. Mar 08, 2024
Top Orthopedic Executives Look Back on 2023
We gathered quotes from top orthopedic executives as they reflected on enabling technology, procedure demand and M&A integration progress. Mar 07, 2024
Orthofix to Fully Leverage Enabling Tech Under New Leadership
The company grew in the mid-single-digits on a pro forma basis in 2023 and is focused on leveraging its unique place in the market. Mar 06, 2024
Paragon 28 Looks to Scale for Next Phase of Growth
The company grew 19% in 2023 despite contending with supply chain constraints and could growth another 20% in 2024. Mar 04, 2024
